Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
3.120
+0.260 (9.09%)
At close: Mar 6, 2026, 4:00 PM EST
3.010
-0.110 (-3.53%)
After-hours: Mar 6, 2026, 7:59 PM EST
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $286.66 million as of March 6, 2026. Its market cap has increased by 304.51% in one year.
Market Cap
286.66M
Enterprise Value
209.87M
1-Year Change
304.51%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $286.66M, an increase of 461.77%. That is a compound annual growth rate of 48.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 286.66M | 112.24% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 307.80M |
| Cabaletta Bio | 305.16M |
| C4 Therapeutics | 296.64M |
| Silence Therapeutics | 294.27M |
| ALX Oncology Holdings | 289.95M |
| Aldeyra Therapeutics | 288.88M |
| AC Immune | 276.05M |
| OmniAb | 273.64M |